Genetic variants in the c-reactive protein gene are associated with microangiopathic ischemic stroke

Cerebrovascular Diseases

Volumn 30, Issue 5, 2010, Pages 476-482

  Kuhlenbaeumer, Gregor ^a,b   Huge, Andreas ^b   Berger, Klaus ^b   Kessler, Christof ^c   Voelzke, Henry ^c   Funke, Harald ^d   Stoegbauer, Florian ^e   Stoll, Monika ^b   Ringelstein, E Bernd ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e Andreas Bannowsky Ltd   (Germany)

Author keywords

Cerebral microangiopathy; Stroke genetics; Trial of ORG 10172 in Acute Stroke Treatment classification

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CASE CONTROL STUDY; CEREBRAL MICROANGIOPATHY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERMANY; GROUPS BY AGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MICROVESSELS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE; THROMBOTIC MICROANGIOPATHIES; VASCULAR DISEASES;

EID: 77956084513     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319021     Document Type: Article

References (35)

1. Flossmann E, Schulz UG, Rothwell PM: Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004; 35: 212-227.
2. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS: Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003; 34: 1364-1369.
3. Schulz UG, Flossmann E, Rothwell PM: Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 2004; 35: 819-824.
4. Bak S, Gaist D, Sindrup SH, Skytthe A, Christensen K: Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke 2002; 33: 769-774.
5. Adams HP Jr, Woolson RF, Biller J, Clarke W: Studies of ORG 10172 in patients with acute ischemic stroke. TOAST study group. Haemostasis 1992; 22: 99-103.
6. Turner ST, Jack CR, Fornage M, Mosley TH, Boerwinkle E, de Andrade M: Heritability of leukoaraiosis in hypertensive sibships. Hypertension 2004; 43: 483-487.
7. Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A, D'Agostino RB, De Carli C: Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 2004; 35: 1609-1613. (Pubitemid 38823634)
8. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F: Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005; 4: 371-380.
9. Andersson J, Johansson L, Ladenvall P, Wiklund PG, Stegmayr B, Jern C, Boman K: C-reactive protein is a determinant of firstever stroke: prospective nested case-referent study. Cerebrovasc Dis 2009; 27: 544-551.
10. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J: C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-140.
11. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, Liu K, Williams OD, Iribarren C, Lewis EC, Fornage M, Boerwinkle E, Gross M, Jaquish C, Nickerson DA, Myers RM, Siscovick DS, Reiner AP: Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005; 77: 64-77.
12. Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R, Cook NR, Ridker PM, Kwiatkowski DJ: Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005; 69: 623-638.
13. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, Cushman M, Bis JC, Zeng D, Lin D, Kuller LH, Nickerson DA, Psaty BM, Tracy RP, Reiner AP: Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006; 296: 2703-2711.
14. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P: Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006; 37: 2018-2023.
15. Reitz C, Berger K, de Maat MP, Stoll M, Friedrichs F, Kardys I, Witteman JC, Breteler MM: CRP gene haplotypes, serum CRP, and cerebral small-vessel disease: the Rotterdam scan study and the MEMO study. Stroke 2007; 38: 2356-2359.
16. Arenillas JF, Massot A, Alvarez-Sabin J, Fernandez- Cadenas I, del Rio-Espinola A, Chacon P, Quintana M, Molina CA, Rovira A, Montaner J: C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses. Cerebrovasc Dis 2009; 28: 95-102.
17. Den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ, Dippel DW: C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol 2009, E-pub ahead of print.
18. Berger K, Stögbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H: The Glu- 298Asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum Genet 2006; 121: 169-178.
19. Kuhlenbäumer G, Berger K, Huge A, Lange E, Kessler C, John U, Funke H, Nabavi DG, Stögbauer F, Ringelstein EB, Stoll M: Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort. J Neurol Neurosurg Psychiatry 2006; 77: 521-524.
20. Schmidt WP, Heuschmann P, Taeger D, Henningsen H, Buecker-Nott HJ, Berger K: Determinants of IV heparin treatment in patients with ischemic stroke. Neurology 2004; 63: 2407-2409.
21. John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S, Kessler C: Study of Health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Präventivmed 2001; 46: 186-194.
22. Schmidt WP, Berger K, Taeger D, Lay M, Bucker-Nott HJ, Kolominsky-Rabas P: Influence of institutional factors in neurological, medical and geriatric departments on length of stay in patients with stroke. Dtsch Med Wochenschr 2003; 128: 979-983.
23. Purcell S, Cherny SS, Sham PC: Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
24. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
25. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
26. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57: 289-300.
27. Ringelstein EB, Nabavi DG: Cerebral small vessel diseases: cerebral microangiopathies. Curr Opin Neurol 2005; 18: 179-188.
28. Fisher CM: Lacunes, small deep cerebral infarcts. Neurology 1965; 15: 774-784.
29. Lammie GA: Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002; 12: 358-370.
30. Fassbender K, Bertsch T, Mielke O, Muhlhauser F, Hennerici M: Adhesion molecules in cerebrovascular diseases: evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999; 30: 1647-1650.
31. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS: Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126: 424-432.
32. Hassan A, Gormley K, O'Sullivan M, Knight J, Sham P, Vallance P, Bamford J, Markus H: Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 2004; 35: 654-659.
33. Den Hertog HM, van den Herik EG, Dippel DW, Koudstaal PJ, de Maat MP: Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke. Cerebrovasc Dis 2010; 29: 372-375.
34. Schmidt R, Schmidt H, Pichler M, Enzinger C, Petrovic K, Niederkorn K, Horner S, Ropele S, Watzinger N, Schumacher M, Berghold A, Kostner GM, Fazekas F: C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study. Stroke 2006; 37: 2910-2916.
35. Van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM: C-reactive protein and cerebral small-vessel disease. The Rotterdam Scan Study. Circulation 2005; 112: 900-905.